HKSE - Delayed Quote HKD

Everest Medicines Limited (1952.HK)

42.700
-0.600
(-1.39%)
At close: May 23 at 4:08:26 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
706,678
706,678
125,932
12,792
54
Cost of Revenue
179,794
179,794
34,414
4,645
23
Gross Profit
526,884
526,884
91,518
8,147
31
Operating Expense
1,270,788
1,270,788
923,453
1,408,346
1,049,303
Operating Income
-743,904
-743,904
-831,935
-1,400,199
-1,049,272
Net Non Operating Interest Income Expense
73,024
73,024
84,608
32,887
24,065
Pretax Income
-1,041,375
-1,041,375
-844,463
-247,275
-1,008,719
Tax Provision
0
0
0
8
0
Net Income Common Stockholders
-1,041,375
-1,041,375
-844,463
-247,283
-1,008,719
Diluted NI Available to Com Stockholders
-1,041,375
-1,041,375
-844,463
-247,283
-1,008,719
Basic EPS
-3.27
-3.24
-2.70
-0.83
-3.44
Diluted EPS
-3.27
-3.24
-2.70
-0.83
-3.44
Basic Average Shares
322,428.501
320,917.606
313,062.809
297,634.997
293,272.152
Diluted Average Shares
322,428.501
320,917.606
313,062.809
297,634.997
293,272.152
Total Operating Income as Reported
-1,117,044
--
-932,738
-256,800
-1,026,332
Total Expenses
1,450,582
1,450,582
957,867
1,412,991
1,049,326
Net Income from Continuing & Discontinued Operation
-1,041,375
-1,041,375
-844,463
-247,283
-1,008,719
Normalized Income
-685,454
-685,454
-794,732
-1,207,073
-1,002,267
Interest Income
95,213
95,213
107,667
38,478
28,881
Interest Expense
22,189
22,189
23,059
5,591
4,816
Net Interest Income
73,024
73,024
84,608
32,887
24,065
EBIT
-1,019,186
-1,019,186
-821,404
-241,684
-1,003,903
EBITDA
-885,568
-885,568
-744,628
-198,912
-972,779
Reconciled Cost of Revenue
179,794
179,794
34,414
4,645
23
Reconciled Depreciation
133,618
133,618
76,776
42,772
31,124
Net Income from Continuing Operation Net Minority Interest
-1,041,375
-1,041,375
-844,463
-247,283
-1,008,719
Total Unusual Items Excluding Goodwill
-355,921
-355,921
-49,731
1,279,720
-6,452
Total Unusual Items
-355,921
-355,921
-49,731
1,279,720
-6,452
Normalized EBITDA
-529,647
-529,647
-694,897
-1,478,632
-966,327
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
319,930
0
12/31/2021 - 10/9/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1167.HK JACOBIO-B
4.460
-7.28%
 
2162.HK Keymed Biosciences Inc.
40.300
-0.98%
 
2171.HK CARsgen Therapeutics Holdings Limited
20.400
-10.13%
 
2142.HK HBM Holdings Limited
8.810
-3.72%
 
394800.KQ 3billion
6,500.00
-2.26%
 
002287.SZ Tibet Cheezheng Tibetan Medicine Co., Ltd.
24.46
+0.45%
 
688331.SS RemeGen Co., Ltd.
57.83
+2.08%
 
603392.SS Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
68.10
-0.42%
 
9969.HK InnoCare Pharma Limited
10.600
-3.28%
 
476040.KQ ORGANOIDSCIENCES
40,950.00
-10.10%